Month: November 2018

People living with Parkinson’s likely have invisible disabilities and face many barriers as they go about their daily lives. Invisible disabilities include sight, hearing, learning, and speech impediments; diabetes; anxiety; chronic pain; sleep disorders and chronic fatigue. Ontario was the first province in Canada and one of the first jurisdictions in the world, to enact … Read more

Dr. Martin Parent, an associate professor at Laval University’s Department of Psychiatry and Neuroscience, is studying the cause of dyskinesia, uncontrolled movements that are a side effect of the levodopa therapy that is still the best drug treatment for Parkinson’s disease. He and his colleagues will be using an innovative new gene-editing technology to manipulate the … Read more

Up to 20 percent of people with Parkinson’s disease who take a new class of drugs to help reduce their stiffness, shakiness, slowness or unsteadiness have encountered an unwanted side-effect: impulsivity. Although the drugs, ropinirole and pramipexole, are effective at reducing motor control problems, the unwanted impulsivity can lead people into destructive behaviours. At the … Read more

It’s never too early to start estate planning. And you should update your Will after any major life event, such as a birth, divorce, death or change to your financial status. Without proper estate planning, you will not be able to influence how, when, and to whom your assets will be distributed after you pass. … Read more

This annual event provides an opportunity for community members to unite in the fight against Parkinson’s disease, with all funds raised going to Parkinson Canada, the definitive voice of the over 100,000 Canadians living with Parkinson’s today. On Saturday, November 3rd, the Lows in Motion organizing committee welcomed yet another sellout crowd to Saskatoon’s Prairieland … Read more